Pharmanutra Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	17.45	16.61	12.83	15.05	13.77	14.07
Depreciation & Amortization	3.48	3.34	2.42	1.15	1.01	0.93
Other Amortization	0.17	0.17	-	-	-	-
Provision & Write-off of Bad Debts	0.24	0.14	0.21	0.17	0.15	1.25
Other Operating Activities	0.67	1.19	1.41	0.81	1.26	0.36
Change in Accounts Receivable	-2.64	-2.98	2.22	-5.15	-1.77	-1.28
Change in Inventory	-2.26	1.22	-2.91	-2.4	-0.97	-0.04
Change in Accounts Payable	1.97	1.43	-0.78	7.14	2.58	-0.99
Change in Income Taxes	0.03	0.02	2.55	-3.04	3.59	-1.62
Change in Other Net Operating Assets	-4.65	-0.7	-5.87	3.74	0.81	-0.89
Operating Cash Flow	14.45	20.5	12.09	17.47	20.41	11.8
Operating Cash Flow Growth	-36.83%	69.56%	-30.77%	-14.44%	73.02%	-1.54%
Capital Expenditures	-4.02	-4.25	-13.25	-26.16	-4.99	-1.68
Sale of Property, Plant & Equipment	0.44	0.66	0.55	0.27	0.08	0.35
Investment in Securities	0.27	-	-	0.25	-	-
Other Investing Activities	0.25	1.38	-2.01	-1.08	-0.64	0.73
Investing Cash Flow	-3.07	-2.21	-14.7	-26.72	-5.54	-0.6
Short-Term Debt Issued	-	-	-	-	-	0
Long-Term Debt Issued	-	0.62	10.99	15.41	5.41	-
Total Debt Issued	0.98	0.62	10.99	15.41	5.41	0
Short-Term Debt Repaid	-	-	-	-	-	-3.76
Long-Term Debt Repaid	-	-6.11	-0.7	-4.04	-0.72	-0.98
Total Debt Repaid	-4.48	-6.11	-0.7	-4.04	-0.72	-4.74
Net Debt Issued (Repaid)	-3.5	-5.49	10.29	11.38	4.69	-4.74
Issuance of Common Stock	0.08	-	-	-	-	-
Repurchase of Common Stock	-0.6	-0.55	-1.65	-2.36	-	-0.03
Common Dividends Paid	-9.59	-8.17	-7.71	-6.85	-6.49	-4.45
Other Financing Activities	-0.82	-7.38	-1.44	-0.27	-0.12	0.73
Financing Cash Flow	-14.43	-21.59	-0.52	1.89	-1.92	-8.5
Miscellaneous Cash Flow Adjustments	14.06	-	-	-	-	-
Net Cash Flow	11.01	-3.31	-3.13	-7.36	12.95	2.7
Free Cash Flow	10.42	16.25	-1.16	-8.69	15.43	10.12
Free Cash Flow Growth	-46.33%	-	-	-	52.49%	42.08%
Free Cash Flow Margin	8.20%	13.99%	-1.15%	-10.46%	22.64%	17.82%
Free Cash Flow Per Share	1.09	1.69	-0.12	-0.90	1.59	1.04
Levered Free Cash Flow	11.88	12.86	2.25	-14.67	11.35	5.51
Unlevered Free Cash Flow	12.35	13.53	2.75	-14.63	11.36	5.53
Change in Working Capital	-7.55	-1.01	-4.78	0.29	4.23	-4.82

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.